Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Where to invest $25K in 2023 according to experts

Masterworks
Finance
June 16, 2023
Share
Tweet
Share

This article is sponsored by Masterworks, the art investment platform.

Right now, there are millions of physicians standing at a crossroads.

More than 40% of active physicians are expected to reach retirement age over the next ten years, and according to Fidelity, the average physician needs about $2.4 million to retire comfortably.

While you’re most likely maxing out your IRA and investing in traditional assets like stocks and bonds, a recent study out of Goldman Sachs shows there could be a better way.

In short, they discovered that putting up to one-third of your portfolio into alternative assets can provide higher returns with less volatility than a traditional stock and bond portfolio.

And they’re not the only major investment firm recommending higher allocations in alternatives.

BlackRock, the world’s largest asset manager with $10 trillion in assets, advises their clients to put up to 20% into alternatives. CalPERS, the California Public Employees’ Retirement System, one of the country’s largest pension systems, allocates 30% to alternatives. With $41 billion in assets, Yale University’s endowment fund invests 60% in alternatives.

The one alternative asset to watch in 2023 and beyond

A recent study by the IMF showed the ultra-rich have been able to grow their wealth three times faster than the average investor because they allocate a greater percentage of their wealth to alternatives.

And while many physicians have probably looked into investing in alternatives like gold or real estate, one alternative asset has outpaced both of these assets by more than three to one over the past 26 years.

In fact, this asset even outpaced the S&P 500 by 131% over the same time period.

I’m talking about blue-chip art.

And while most people probably think investing in art is only for the ultra-rich, recent regulatory changes have made investing in this exclusive asset class easier than ever.

ADVERTISEMENT

Art can help you “create a lasting legacy.”

JP Morgan says art is a “powerful financial asset” that can help you “create a lasting legacy.”

Which can be true, especially when it comes to artwork from iconic artists like Banksy and Picasso.

For example, take Banksy’s Girl with a Balloon painting, which originally sold for $1.4 million in 2018.  Three years later, the same painting sold for $25.4 million, a 1,800% increase in just a few short years.

You don’t have to be an art expert to understand that these are impressive returns. And while this particular painting is an outlier, the long-term trend is clear.

From 2003 to 2022, Banksy’s record price at auction* for his works saw an average growth of 67.1% a year, an impressive return for any asset class.

Unfortunately, most investors don’t have a million or more to purchase a single iconic piece.

But thanks to one NY fintech called Masterworks, you no longer need to have millions to own a piece of history.

Diversifying your portfolio with art

Masterworks has made it their mission to make art more investible.

Masterworks offers fractional investing in multi-million dollar paintings from famous artists like Picasso, Banksy, and Basquiat at a fraction of the cost of buying the entire painting.

With over $600 million under management and over 200 paintings already offered, Masterworks is revolutionizing the art investing world.

By opening up this one private, secretive “billionaire’s market” to investors all around the globe.

All you have to do is set up a FREE account, and in just 15 minutes, you could be on your way to investing in this blue-chip art alongside the world’s most elite hedge fund managers, entrepreneurs, and celebrities.

They’ve already built an impressive track record.

Masterworks has a world-class research team, led by a Harvard data scientist, that’s built a proprietary database that helps them find “excess alpha” in the art markets. This tool gives them a quantitative edge in this very exclusive market.

So far, the results have been impressive.

Since 2019, Masterworks has exited 13 artworks, all of them profitable, with 8 of the 13 artworks delivering 20%+ in net annualized returns.

That includes nine successful exits in 2022, with the last three delivering +10.4%, +13.9%, and +35% in net annualized gains, when nearly every other asset class was crashing.

To date, Masterworks has sold over $45 million in artwork and returned the proceeds to investors.

Masterworks makes art investing easy.

According to UBS, 77% of ultra-rich collectors are bullish on art in 2023, and 61% already allocate at least 10% of their portfolios to art.

Jeff Bezos, Bill Gates, and Oprah Winfrey all have collections valued in the hundreds of millions. And the “hedge fund king,” Steve Cohen has amassed a collection worth over $1 billion.

Don’t you think it’s time to consider investing at least 5% of your portfolio into art?

Getting started with Masterworks is simple. Click this link, and it will take you to a short application page that should take you less than two minutes to complete.

Once you’re finished, a qualified financial advisor will reach out to help you finish setting up your investor profile.

As soon as you’re approved, you’ll get access to all their latest offerings, which can include paintings from iconic artists like Banksy and Picasso.

What are you waiting for?

Masterworks is unlocking an asset class that was once only available to the ultra-rich, and they’re inviting readers to open a free, no-obligation account today.

It only takes seconds to apply, and new offerings are added every week. But with over 700,000 members and counting, these offerings can sell out quickly.

But KevinMD readers can click here to skip the waitlist and invest in multi-million dollar paintings.

P.S. Masterworks has launched a new fund-like product called the “diversified art portfolio,” or the “DAP” for short. The DAP lets you invest in a pool of 60 to 80 paintings that their team handpicks for you. But you have to be an accredited investor to access this feature.

* A “record price” reflects the highest hammer price (excluding auction house buyer’s premium) achieved at a public auction for any artwork by a particular artist. The art market considers the progression of record hammer prices to be an indication of an artist’s market momentum and growth rate.

This article is provided for informational and educational purposes only. It is not intended to be investment advice and should not form the basis of an investment decision.

Masterworks is the first platform for buying and selling shares representing an investment in iconic artworks. Build a diversified portfolio of expertly-vetted works curated by our industry-leading research team. Please review Masterworks’ disclosures and see important Regulation A disclosures at masterworks.io/cd.

Prev

Breaking barriers in Medicaid access [PODCAST]

June 16, 2023 Kevin 0
…
Next

Revolutionizing postpartum care: Transforming breastfeeding support for families

June 17, 2023 Kevin 0
…

Tagged as: Practice Management

Post navigation

< Previous Post
Breaking barriers in Medicaid access [PODCAST]
Next Post >
Revolutionizing postpartum care: Transforming breastfeeding support for families

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Masterworks

  • The “Blue Zone” asset: This unconventional asset is found in some of the world’s healthiest portfolios

    Masterworks
  • The “Physician’s Gambit”: an unconventional, but effective wealth preservation play for 2022

    Masterworks
  • The estimated $1.7 trillion legacy asset Jeff Bezos loves. (Physicians can easily diversify their portfolio with this.)

    Masterworks

Related Posts

  • A paradigm shift in acute pain assessment and management

    Myles Gart, MD
  • The slippery slope of utilization management

    Sneha Tella, MD
  • Medication management and how consultant pharmacists can help

    Michael R. McGuire
  • It’s time to learn the basics of financial management in medical school

    Aashish Shah
  • Think twice before prescribing opioids as a first-line treatment for pain

    Gary Call, MD
  • The promises and limits of a fentanyl vaccine

    Julie Craig, MD

More in Finance

  • The hidden impact of denials on health care systems

    Diana Ortiz, JD
  • Why physicians are unlike the “average” investor

    David B. Mandell, JD, MBA
  • Signing bonuses and taxes: What physicians should know

    Shane Tenny, CFP
  • 5 steps to ride out a non-compete without uprooting your family

    Stanley Liu, MD
  • What every physician should know before buying into a medical practice

    Dennis Hursh, Esq
  • Navigating your 457 plan: key steps for physicians changing jobs

    Shane Tenny, CFP

More in Sponsored

  • Expert Q&A: Dr. Jared Pelo, ambient clinical pioneer, explains how Dragon Copilot helps clinicians deliver better care

    Jared Pelo, MD & Microsoft & Nuance Communications
  • Disability insurance done right: the financial lifeline every physician needs

    The Podcast by KevinMD
  • The buzz around GSI disability insurance for residents: Why it’s gaining popularity and how to take advantage

    Set for Life Insurance
  • Why your disability insurance agent might not offer the most optimized policy

    Set for Life Insurance
  • Patient safety in focus: Helping to address risk factors associated with non-ventilator hospital-acquired pneumonia

    Stryker Oral Care & The Podcast by KevinMD
  • Strategies for patient-centered and employee-focused care

    NRC Health & The Podcast by KevinMD
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in mental health: a new frontier for therapy and support

      Tim Rubin, PsyD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in mental health: a new frontier for therapy and support

      Tim Rubin, PsyD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...